MARGONI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.248
AS - Asia 3.383
EU - Europa 1.972
SA - Sud America 669
AF - Africa 601
Continente sconosciuto - Info sul continente non disponibili 125
OC - Oceania 56
Totale 11.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.885
SG - Singapore 961
IT - Italia 783
CN - Cina 614
BR - Brasile 403
VN - Vietnam 382
HK - Hong Kong 371
BD - Bangladesh 196
FR - Francia 147
IN - India 120
NL - Olanda 109
DE - Germania 105
CA - Canada 76
PL - Polonia 76
FI - Finlandia 71
SE - Svezia 63
TR - Turchia 63
GB - Regno Unito 58
AR - Argentina 54
IQ - Iraq 53
RU - Federazione Russa 48
EC - Ecuador 45
PH - Filippine 44
KR - Corea 42
MX - Messico 39
AT - Austria 34
ES - Italia 34
ZA - Sudafrica 33
JO - Giordania 32
PK - Pakistan 32
ID - Indonesia 30
JP - Giappone 30
UA - Ucraina 29
MY - Malesia 28
VE - Venezuela 28
CI - Costa d'Avorio 27
IE - Irlanda 27
PE - Perù 27
CO - Colombia 26
SA - Arabia Saudita 26
UZ - Uzbekistan 26
BJ - Benin 25
CR - Costa Rica 24
DZ - Algeria 24
JM - Giamaica 24
AL - Albania 23
EG - Egitto 23
PS - Palestinian Territory 23
TN - Tunisia 23
CH - Svizzera 22
PY - Paraguay 22
AO - Angola 21
AZ - Azerbaigian 21
ET - Etiopia 21
MK - Macedonia 21
RO - Romania 21
MR - Mauritania 20
PT - Portogallo 20
TJ - Tagikistan 20
TW - Taiwan 20
BO - Bolivia 19
DK - Danimarca 19
HN - Honduras 19
KZ - Kazakistan 19
IS - Islanda 18
MA - Marocco 18
ME - Montenegro 18
NC - Nuova Caledonia 18
RS - Serbia 18
ZW - Zimbabwe 18
AE - Emirati Arabi Uniti 17
BE - Belgio 17
IR - Iran 17
MD - Moldavia 17
NP - Nepal 17
BF - Burkina Faso 16
BZ - Belize 16
GF - Guiana Francese 16
HU - Ungheria 16
LA - Repubblica Popolare Democratica del Laos 16
LY - Libia 16
UY - Uruguay 16
XK - ???statistics.table.value.countryCode.XK??? 16
GA - Gabon 15
GT - Guatemala 15
IL - Israele 15
KG - Kirghizistan 15
LC - Santa Lucia 15
MN - Mongolia 15
NI - Nicaragua 15
ZM - Zambia 15
CD - Congo 14
CY - Cipro 14
CZ - Repubblica Ceca 14
KE - Kenya 14
LB - Libano 14
LV - Lettonia 14
SI - Slovenia 14
BY - Bielorussia 13
CL - Cile 13
Totale 10.336
Salva come PNG Salva come JPEG
Città #
San Jose 613
Ashburn 581
Singapore 573
Hong Kong 331
Fairfield 269
Santa Clara 221
Chandler 166
Woodbridge 135
Milan 123
Ho Chi Minh City 119
Houston 100
Beijing 98
Cambridge 98
Los Angeles 97
Seattle 87
Hanoi 85
Council Bluffs 65
Lauterbourg 63
Wilmington 57
Hefei 55
Boardman 54
New York 48
Munich 47
Rome 46
The Dalles 46
Ann Arbor 45
São Paulo 41
Chicago 38
Bytom 37
Istanbul 37
Buffalo 34
Helsinki 34
Amman 31
Guangzhou 29
Medford 28
Princeton 28
Abidjan 26
Orem 26
Cotonou 25
Roxbury 25
Da Nang 22
Montreal 22
Naples 22
Padova 22
Tashkent 21
Baku 20
Dallas 20
Dushanbe 20
Salt Lake City 20
San Diego 20
Turku 20
Vienna 20
Baghdad 19
Brooklyn 19
Nouakchott 19
Seoul 19
Shanghai 19
Des Moines 18
Dublin 18
Harare 17
Luanda 17
Noumea 17
Nuremberg 17
Paris 17
Quito 17
Warsaw 17
Addis Ababa 16
Cagliari 16
Denver 16
Redondo Beach 16
San José 16
Bologna 15
Castries 15
Lima 15
Lusaka 15
Tokyo 15
Vientiane 15
Amsterdam 14
Bishkek 14
Charlotte 14
Chennai 14
Frankfurt am Main 14
Guayaquil 14
Mexico City 14
Podgorica 14
Rio de Janeiro 14
Skopje 14
Ulan Bator 14
Verona 14
Bari 13
Biên Hòa 13
Cayenne 13
Johannesburg 13
Kampala 13
Kingston 13
Lahore 13
Las Vegas 13
Libreville 13
Managua 13
Ouagadougou 13
Totale 5.641
Salva come PNG Salva come JPEG
Nome #
Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot Study 491
Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset. 290
Early red nucleus atrophy in relapse-onset multiple sclerosis 270
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 257
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis 248
No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab 248
Neuropsychological awareness in pediatrics (NAP): Proposal of a new cognitive self-report questionnaire for pediatric multiple sclerosis patients 245
Selective Cerebellar Atrophy Associates with Depression and Fatigue in the Early Phases of Relapse-Onset Multiple Sclerosis 233
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 228
A new Italian family with HTRA1 mutation associated with autosomal-dominant variant of CARASIL: Are we pointing towards a disease spectrum? 228
Neurite orientation dispersion and density imaging discloses early changes in the normal-appearing white matter in paediatric multiple sclerosis 212
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis 204
Quantification of normal-appearing white matter damage in early relapse-onset multiple sclerosis through neurite orientation dispersion and density imaging 204
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study 203
Quantificazione del danno microstrutturale nella sclerosi multipla attraverso il rapporto delle sequenze pesate in T1 e T2: uno studio multicentrico 202
Isolated choroid plexus involvement in a case of granulomatosis with polyangiitis negative for antineutrophil cytoplasmic antibodies (ANCA) 193
Slowly Progressive Optic Perineuritis as the First Clinical Manifestation of Sarcoidosis 193
Ophthalmoplegic migraine: Could electroencephalogram still be a useful tool to better understand the pathogenetic mechanism? 177
Effects of disease modifying therapies on brain and grey matter atrophy in relapsing remitting multiple sclerosis 175
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis 175
Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis 169
A novel mutation in ABCD1 unveils different clinical phenotypes in a family with adrenoleukodystrophy 168
Very late-onset recurrent myelitis in a patient diagnosed with antiphospholipid syndrome: A puzzle of autoimmunity 165
Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre 164
Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosis 164
Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques 164
Dynamics of choroid plexus volume is associated with the presence and development of fatigue in multiple sclerosis 159
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 158
Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre 157
Hematoma of Meckel's cave: a rare possible symptomatic trigeminal neuralgia 152
Multiple sclerosis diagnosis: a biologically driven perspective 146
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis 146
Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers 143
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis 138
Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study 135
Idiopathic hypertrophic cranial pachymeningitis as a rare cause of status epilepticus 135
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 133
Monoaminergic network abnormalities are associated with fatigue in pediatric multiple sclerosis 130
Chronic Active Lesions and Larger Choroid Plexus Explain Cognition and Fatigue in Multiple Sclerosis 128
Ophthalmoplegic migraine: could electroencephalogram still be a useful tool to better understand the pathogenetic mechanism? 126
Cerebellar pathology and disability worsening in relapsing‐remitting multiple sclerosis: a retrospective analysis from the CombiRx trial 126
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 123
Spinal Cord Abnormalities in Early Pediatric Multiple Sclerosis 123
Assessment of central vein sign and paramagnetic rim lesions in pediatric multiple sclerosis 118
Emerging Perspectives on MRI Application in Multiple Sclerosis: Moving from Pathophysiology to Clinical Practice 117
Soma and neurite density abnormalities of paramagnetic rim lesions and core-sign lesions in multiple sclerosis 117
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic 117
Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein–immunoglobulin G-associated Disease 116
Ketogenic diet in migraine treatment: a brief but ancient history 116
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 115
Disability worsening outcome in multiple sclerosis based on EDSS: does half a point matter? 115
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 114
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 112
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 110
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities 109
Subventricular Zone Microstructure in Pediatric‐Onset Multiple Sclerosis 108
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 108
Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis 108
Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis 103
Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis 100
Behind the scenes: exploring neurological journal editors’ work habits, decisions, and potential sources of conflict of interest 99
The diagnostic workup of children with the radiologically isolated syndrome differs by age and by sex 98
Cervical spinal cord gray matter damage predicts disability worsening in multiple sclerosis: a longitudinal study 95
A Fully Automatic Method to Segment Choroid Plexuses in Multiple Sclerosis Using Conventional MRI Sequences 95
Tumefactive demyelinating lesions: a challenging first manifestation of multiple sclerosis 94
The ageing central nervous system in multiple sclerosis: the imaging perspective 91
Influence of cardiorespiratory fitness and MRI measures of neuroinflammation on hippocampal volume in multiple sclerosis 81
Thalamic nuclei volume partially mediates the effects of aerobic capacity on fatigue in people with multiple sclerosis 78
Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study 76
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study 75
Paramagnetic rim and core sign lesions in paediatric multiple sclerosis patients 72
Structural and functional imaging features of cognitive phenotypes in pediatric multiple sclerosis 63
Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-Cd20 Monoclonal Antibodies for Multiple Sclerosis Treatment 51
Smouldering disease in paediatric-onset multiple sclerosis 37
null 18
Totale 11.054
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.868
article - articoli 29.484
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.352
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022382 0 14 36 19 37 46 24 33 49 15 29 80
2022/2023359 55 29 22 36 48 47 7 29 45 14 20 7
2023/2024382 11 28 27 44 37 29 40 22 34 33 36 41
2024/20251.624 12 95 77 57 222 37 54 146 107 84 308 425
2025/20267.040 357 570 1.055 1.174 559 267 816 645 560 347 359 331
2026/2027445 327 118 0 0 0 0 0 0 0 0 0 0
Totale 11.054